Use of monoclonal anti-EGFR antibody in the radioimmunotherapy of malignant gliomas in the context of EGFR expression in grade III and IV tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/16796458

Download in:

View as

General Info

PMID
16796458